Contracts › 75A50124F61010
75A50124F61010: The Purpose of This Task Order Is to Procure Storage and Stability for Antigens and Adjuvants From Prior Contracts for the Department of Health and Human Services Under Idiq 75A50122D000002 During Base Period Yr. 3. Period of Performance: February
Awarded to Glaxosmithkline, Llc by Office of Assistant Secretary for Preparedness and Response.
$7.8Mobligated
$7.8Mpotential value
21 May 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50124F61010 |
|---|---|
| Vehicle | 75A50122D00002 |
| Awardee | Glaxosmithkline, Llc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN14 Health R&D Services; Health Care Services; R&D Administrative Expenses |
| Place of performance | NC |
| Period of performance | 21 February 2024 to 21 May 2027 |
| Potential end | 21 May 2027 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record